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Aim: To adapt the Asthma Quality of Life Questionnaire (AQLQ(S)), the Asthma Control Ques-
tionnaire (ACQ) and the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ(S)) for
a personal digital assistant (Palm TX) and to examine the validity of the electronic versions
by comparing them with the original paper versions.
Methods: 84 adults with asthma and 32 with rhinitis were randomised to complete either the
paper or the electronic version first. After 2 h, they completed the other version.
Results: 68 asthma and 27 rhinitis patients provided analysable data. For the AQLQ(S) and
RQLQ(S) differences between paper and electronic were significant. Concordance between
paper and electronic, evaluated using an intraclass correlation coefficient were: AQLQZ 0.92,
ACQZ 0.90 and RQLQZ 0.85. Concordance for the individual domains of the AQLQ and RQLQ
ranged from 0.52 to 0.94. These levels of concordance did not reach the a priori defined
requirement for validity.
Conclusions: The significant bias between paper and electronic versions and only modest
concordance provides evidence that patients may respond differently to questionnaires in
different formats and show that different formats must not be used interchangeably.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
The 32-item standardised Asthma Quality of Life Ques-
tionnaire (AQLQ(S))1,2 and the 28-item standardisedFields, Bosham, West Sussex
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(RQLQ(S))3,4 were developed to measure the functional
problems that patients with asthma and rhinoconjunctivitis
experience in their daily lives. The 7-item Asthma Control
Questionnaire (ACQ)5 was developed to measure the
primary clinical goal of asthma management. Patients
respond to each question using a 7-point scale. All three
questionnaires were developed in paper format in which
medium they have undergone extensive validation both in.
PDA versions of questionnaires 933English and other languages. All three questionnaires have
shown strong and consistent measurement properties and
validity.
Many clinicians, academics and commercial companies
are changing from paper to electronic data collection.
A wide range of devices is being used including personal
computers, the Internet, personal digital assistants (PDAs),
scanners, interactive voice response (IVR), etc. Reasons for
electronic data collection include reduced transcription
errors, timed data entry, reduced risk of data loss, reduced
storage space, reduced risk of data tampering and data
collection away from the clinic. However, the validity of
questionnaires may be specific to the method of data
collection. It cannot be assumed that questionnaires vali-
dated using pen and paper are similarly valid when
administered using alternate data collection methods.
In this study, the AQLQ(S), the ACQ and the RQLQ(S)
were adapted for a PDA, the Palm TX. Validity was exam-
ined by comparing patients’ responses to the original paper
and PDA versions.
Materials and methods
Development of the electronic versions
The small screens of PDAs cannot contain a complete
question plus a 7-point response scale. In most cases
a single question and its responses could be fitted on two
consecutive screens but for longer questions, three screens
were required. Screens were carefully formatted and
particular care was taken when rewording was necessary.
Care was also taken to maintain the conceptual accuracy of
the questions and the interval properties of the 7-point
scales. All three questionnaires underwent a cognitive
debriefing in a wide range of patients to ensure ease of use
and accuracy of understanding of the instructions, ques-
tions and response options. The final English version was
adapted for Polish, Russian, Ukrainian, Bulgarian and Czech
using the linguistically validated paper versions in these
languages. All new wording was translated and carefully
checked by the MAPI Research Institute (Lyon, France) who
had done the original linguistic validation for each
language.
Validation
84 adults (17e65 years) with asthma participated in the
AQLQ(S) and ACQ comparison. 32 of these patients also had
rhinoconjunctivitis and were enrolled in the RQLQ(S)
comparison. They were enrolled from patients participating
in a clinical trial conducted by Inflazyme Pharmaceuticals
(Richmond, British Columbia, Canada). For our study,
patients with asthma were required to have AQLQ(S) <6.0
and ACQ >1.5. Patients with rhinitis were required to have
RQLQ(S) >1.5. All patients gave informed consent.
Paper and electronic versions were completed during
a single clinic visit with a two-hour interval in between. The
AQLQ(S) and the ACQ were completed during the clinical
trial screening visit and the RQLQ(S) comparison was done 2
weeks later. Patients were randomised to complete either
the paper or the electronic version first. During the two-hour interval between completions, patients carried out
a non-medical activity (e.g. read, TV, etc.)
Statistical analysis
Overall and domain scores for electronic and paper versions
were compared using a paired t-test. Concordance
between the two methods was examined with an intraclass
correlation coefficient (ICC). It was decided a priori that
concordance between electronic and paper for the AQLQ(S)
and the RQLQ(S) would be acceptable if the ICC for the
overall score was 0.95 or greater. Concordance for the ACQ
was required to be 0.90 or higher. These values are slightly
lower than the testeretest reproducibility of the paper
versions completed one week apart1e5 and in keeping with
levels of concordance observed in previous validation
studies of electronic devices.6,7 The ACQ was analysed both
with and without FEV1 data.
Results
Of the 84 patients with asthma who were randomised, 66
patients completed the AQLQ(S) and 68 completed the ACQ
in both paper and electronic format and were included in
the analysis. Three subjects were excluded because they
completed the paper version in Ukrainian and the elec-
tronic in Russian. 16 were excluded from the AQLQ(S) and
14 from the ACQ analysis because they completed the
electronic version of the questionnaires twice due to
a technical fault with the device. 27 patients completed
both paper and electronic versions of the RQLQ(S) and were
included in the analysis. Six patients were excluded for
missing electronic data and one was excluded for missing
paper data.
Overall and domain scores, paired t-test results and
concordance (intraclass correlation coefficients) for all
three questionnaires are shown in Table 1. For the AQLQ(S),
differences were significant for the overall score
(pZ 0.009) and two of the four domains (pZ 0.007,
pZ 0.01). Concordance was ICCZ 0.92 which was below
the 0.95 level required for validity. For the ACQ, the
difference did not reach statistical significance (pZ 0.12)
and concordance was ICCZ 0.90. Differences for the
RQLQ(S) were the borderline for the overall score
(pZ 0.05) and significant for 2 of the 7 domains. Concor-
dance for the overall score was ICCZ 0.84 which was well
below the 0.95 level required for validity.
Discussion
The results of this study suggest that even with very careful
formatting, rewording, linguistic validation and a thorough
cognitive debriefing in patients, questionnaires adapted for
another medium may not give data that is consistent with
the original validated version. The study shows that these
versions of the AQLQ(S) and RQLQ(S) on to the Palm TX gave
inadequate concordance between paper (gold standard)
and PDA to support the validity of these PDA versions. Of
serious concern was the bias shown for the overall AQLQ(S)
and RQLQ(S) scores and some of their domains. For the
AQLQ(S), the difference was highly significant (pZ 0.009).














AQLQ(S) overall 3.65 0.72 3.75 0.76 0.10 0.009 0.92 0.92
Symptoms 3.54 0.72 3.60 0.77 0.06 0.14 0.90 0.90
Activities 3.89 0.79 4.01 0.81 0.12 0.007 0.90 0.89
Emotions 3.51 1.09 3.63 1.03 0.12 0.10 0.86 0.85
Environment 3.50 0.95 3.60 0.95 0.11 0.01 0.94 0.94
ACQ 3.04 0.52 2.99 0.56 0.05 0.12 0.90 0.90
ACQ (no FEV1) 2.91 0.58 2.86 0.64 0.05 0.12 0.91 0.90
RQLQ overall 2.79 0.89 2.59 0.99 0.20 0.05 0.87 0.84
Activities 3.04 0.98 3.01 1.05 0.02 0.83 0.83 0.83
Sleep 2.77 1.30 2.75 1.30 0.01 0.96 0.51 0.52
Non-rhinitis symptoms 2.74 1.10 2.47 1.21 0.28 0.04 0.84 0.82
Practical problems 3.25 1.23 3.02 1.60 0.24 0.15 0.90 0.86
Nasal symptoms 2.95 1.16 2.76 1.31 0.19 0.19 0.82 0.81
Eye symptoms 2.24 1.22 2.01 1.23 0.23 0.15 0.79 0.78
Emotional function 2.81 1.21 2.45 1.50 0.36 0.07 0.75 0.71
934 E.F. Juniper et al.The difference in RQLQ(S) overall score was borderline
(pZ 0.05) but with only 27 patients, the probability of
a type 2 error was high and the bias probably real. Only the
ACQ reached the required concordance for validity and
even this was borderline.
The reason for the bias between paper and electronic is
unclear. The order in which patients completed the two
versions was randomised and therefore bias cannot be
attributed to a learning effect or other external
confounders. It may be that having questions and responses
on different screens or in a changed format influenced how
patients responded. On a different PDA (Palm Treo 650),
the overall RQLQ(S) reached the required concordance with
an ICC of 0.95 but it too showed significant bias in some of
the domains.8 In contrast, large screen electronic versions
of these questionnaires, where instructions, questions and
their response options are on a single screen, concordance
between paper and electronic was high (ICCZ 0.99 and
0.96) with no evidence of bias.6e8
The reason for the poor concordance between paper and
electronic in this study, compared with a previous PDA
study8 is also unclear. One possible reason is that the
electronic configuration and software was not the same in
the two devices. Secondly, this study was appended to
a large multinational clinical trial and attention to protocol
adherence may not have been as good.
Of additional concern was the amount of electronic data
‘lost’ by the PDAs (RQLQ(S): nZ 6) and double entry of
data due to technical faults (AQLQ(S): nZ 16 and ACQ:
nZ 14). Although data integrity is marketed as an advan-
tage of electronic data capture, this study shows that data
losses do occur.
The results of this study and those from IVR validation
studies,9 where significant biases were also observed,
emphasise the importance of checking the validity of all
new formats of questionnaires before they are used either
in clinical practice or research. In addition, the results
show that different formats of the same questionnaire
cannot be used interchangeably.Conflict of interest
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